Abstract
Introduction: Diagnostic and management pathways for lentigo maligna (LM) are challenging, due to the risk of transformation into lentigo malignant melanoma (LMM) of 5–20%. Clinical guidance recommends excisional biopsies of 2–5 mm margins as gold standard. Consistency to this between different clinicians and specialties remains poor. We report our experience.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have